Greg Liang is the Director of Biologics Discovery at ChemPartner, a position held since 2017. With a strong background in biomedical science, they have extensive experience in developing and manufacturing biologics, regulatory affairs, and clinical trials. Prior roles include leadership positions in manufacturing and quality assurance at Acro Biotech, and compliance management at NeoStem and Caladrius Biosciences. Greg has co-authored multiple patents and contributed significantly to numerous successful clinical trials, particularly in cell therapy. They hold a Bachelor's degree in Medicine and a Master's degree in Biochemistry and Nuclear Medicine from Jilin University and Peking Union Medical College, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices